Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Share-based Compensation (2016 - 2025)

MedWellAI (MWAI) has disclosed Share-based Compensation for 9 consecutive years, with $49250.0 as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 2.34% to $49250.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $649917.0, a 1250.48% increase, with the full-year FY2025 number at $599542.0, changed N/A from a year prior.
  • Share-based Compensation was $49250.0 for Q4 2025 at MedWellAI, roughly flat from $49250.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $14.8 million in Q2 2023 to a low of -$8.3 million in Q4 2023.
  • A 5-year average of $1.3 million and a median of $145000.0 in 2022 define the central range for Share-based Compensation.
  • Biggest YoY gain for Share-based Compensation was 3900.0% in 2023; the steepest drop was 5824.14% in 2023.
  • MedWellAI's Share-based Compensation stood at $1.9 million in 2021, then crashed by 92.29% to $145000.0 in 2022, then plummeted by 5824.14% to -$8.3 million in 2023, then skyrocketed by 100.58% to $48125.0 in 2024, then rose by 2.34% to $49250.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Share-based Compensation are $49250.0 (Q4 2025), $49250.0 (Q3 2025), and $49250.0 (Q2 2025).